Peplin
Specialty pharmaceutical company focused on advancing and commercializing medical dermatology products.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
| investor | €0.0 | round | |
| investor | €0.0 Valuation: €0.0 | round | |
* | N/A | Growth Equity VC | |
| Total Funding | 000k | ||
Related Content
LEO Pharma, founded in 1908 and headquartered in Denmark, specializes in dermatology solutions aimed at improving skin health. Serving clients in over 130 countries, the company employs 6,000 professionals across 60 countries. LEO Pharma operates in the pharmaceutical market, focusing on developing, manufacturing, and marketing dermatological treatments. The business model revolves around research and development, producing innovative treatments, and generating revenue through the sale of these products. The company reinvests in knowledge and innovation to maintain its leadership in the dermatology sector.
Keywords: Dermatology, Skin Health, Pharmaceutical, Innovation, Global, Treatments, Research, Development, Manufacturing, Expertise.